
Mark A. Rubin
@markarubin1
Precision Medicine & Prostate Cancer Researcher. Off-target resistance keeps me driven to find a cure! @Unibern šMichigan š“ā°ļø Be part of the solution
ID: 1442119560
https://www.rubinlab.com/ 19-05-2013 20:31:46
2,2K Tweet
2,2K Followers
695 Following

š Do not miss our next SPOC bern/#BCPM joint #SpatialOmics seminar June 13, 3pm CET with Nigel B. Jamieson in person and via Zoom. Registration and info: šspoc-bern.squarespace.com/events #colorectal #cancer Institute of Tissue Medicine and Pathology UniversitƤt Bern Insel Gruppe BioMedical Research Mark A. Rubin SPOC bern


Life lessons from Roger Federer (must watch) 1 Effortless is a myth 2 Belief in yourself has to be earned 3 Grit > Gift 4 Discipline is talent 5 Trust and loving the process is talent 6 You can do your best and still lose 7 Life is bigger than the court

I enjoyed hearing what concerns trainees. The discussion was on point. Impact factor is not the only criterion used to select new faculty. Leadership skills, the ability to ask important questions, the something special you bring, and interpersonal skills count -a lot. UniversitƤt Bern


Honored to welcome over 200 colleagues from National Cancer Institute #cancer centers for the annual #SPORE in #lungcancer workshop in celebration of the 20th anniversary of the discovery of the #EGFR mutation. Smilow Cancer Hospital Roy Herbst Yale School of Medicine Yale Thoracic Surgery Eric Winer, MD OncoAlert



An AI Copilot for Human Pathology published in Nature. When will it take over for the pilot? Bern Center for Precision Medicine UniversitƤt Bern Prostate Cancer Foundation USCAP nature go.nature.com/4ch5kri





Rare histologic transformation of a CTNNB1 (β-catenin) mutated #prostatecancer. The challenge of treatment selected lineage plasticity Prostate Cancer Foundation BioMedical Research bit.ly/4cfvDOZ


So proud of Anke and her first in class work. It is great to see when a trainees idea becomes a reality: Minor intron splicing- a hallmark of cancer Prostate Cancer Foundation Swiss National Science Foundation European Research Council (ERC) UniversitƤt Bern

Iām excited to share our new study of the mechanisms of action of the therapeutic target ONECUT2 in prostate cancer. The protein activates a surprisingly wide range of resistance mechanisms. But we can suppress it with a drug! Prostate Cancer Foundation PCF Science doi.org/10.1093/nar/gkā¦

The DBMR Day of BioMedical Research 2024 is tomorrow! Join us ā there will be plenty of good science to learn from and our awards! UniversitƤt Bern Insel Gruppe @politikaterina Faculty of Medicine, University of Bern Mark A. Rubin


Excellent talk by Prof. @politikaterina on the biology of drug resistance in #LungCancer! UniversitƤt Bern Insel Gruppe Faculty of Medicine, University of Bern Mark A. Rubin


Great to hear about a broad range of biomedical research taking place at BioMedical Research . Congrats to the award winners and our Keynote speaker from Yale School of Medicine Katie Politi. UniversitƤt Bern

Great honor tonight from Mount Sinai AlumniMount Association. Especially want to thank my beloved wife Gabriela ā¤ļøfor supporting me every day through 9 time zones.@MountSinaiAlum




Loss of Pi5P4Ka slows the progression of Pten mutant basal cell model of prostate cancer. Joanna Triscott; Marika Lehner; Andrej Benjak; Matthias Reist; BrookeM Emerling; Charlotte K.Y.Ng; @Simone de Brot; Mark A. Rubin tinyurl.com/48muj6zn